DADC
BMRN icon

D.A. Davidson & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

D.A. Davidson & Co’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Sell
43,601
-462
-1% -$25.3K 0.01% 676
2026
Q1 		$2.49M Buy
44,063
+36,293
+467% +$2.12M 0.02% 621
2025
Q4 		$462K Sell
7,770
-3,104
-29% -$169K ﹤0.01% 1172
2025
Q3 		$589K Buy
10,874
+3,755
+53% +$215K ﹤0.01% 1061
2025
Q2 		$391K Buy
7,119
+331
+5% +$19.5K ﹤0.01% 1145
2025
Q1 		$480K Sell
6,788
-746
-10% -$50.2K ﹤0.01% 1041
2024
Q4 		$495K Buy
+7,534
New +$505K ﹤0.01% 1020
2020
Q3 		– Sell
-5,284
Closed -$652K – 956
2020
Q2 		$652K Sell
5,284
-85
-2% -$8.45K 0.01% 532
2020
Q1 		$454K Buy
5,369
+233
+5% +$20.1K 0.01% 616
2019
Q4 		$434K Buy
5,136
+1,977
+63% +$149K 0.01% 716
2019
Q3 		$213K Buy
+3,159
New +$243K ﹤0.01% 900
2017
Q3 		– Sell
-250
Closed -$22K – 1186
2017
Q2 		$22K Sell
250
-200
-44% -$18.2K ﹤0.01% 1790
2017
Q1 		$39K Buy
450
+65
+17% +$5.78K ﹤0.01% 1607
2016
Q4 		$31K Buy
385
+250
+185% +$21.5K ﹤0.01% 1775
2016
Q3 		$12K Buy
135
+35
+35% +$3.3K ﹤0.01% 1992
2016
Q2 		$7K Hold
100
– – ﹤0.01% 2039
2016
Q1 		$8K Sell
100
-454
-82% -$36.9K ﹤0.01% 1947
2015
Q4 		$58K Hold
554
– – ﹤0.01% 1342
2015
Q3 		$58K Sell
554
-46
-8% -$6.14K ﹤0.01% 1301
2015
Q2 		$82K Hold
600
– – ﹤0.01% 1225
2015
Q1 		$74K Buy
+600
New +$63.6K ﹤0.01% 1263

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

D.A. Davidson & Co's BMRN Position: Q2 2026 in Review

D.A. Davidson & Co reduced its BioMarin Pharmaceuticals (BMRN) stake by 1% in Q2 2026, selling an estimated $25.3K and leaving 43,601 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #676.

D.A. Davidson & Co first reported a position in BMRN in Q1 2015 and has held it in 21 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • D.A. Davidson & Co held 43,601 shares of BioMarin Pharmaceuticals worth $2.49M as of Q2 2026.
  • D.A. Davidson & Co sold 462 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $25.3K.
  • BioMarin Pharmaceuticals made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #676 holding.
  • D.A. Davidson & Co first reported a position in BioMarin Pharmaceuticals in Q1 2015 and has held it in 21 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.